The FDA is meeting this week to consider NurOwn, a much-debated treatment for Lou Gehrig’s disease. The agency says the treatment hasn't been shown to work.
The FDA is meeting this week to consider NurOwn, a much-debated treatment for Lou Gehrig’s disease. The agency says the treatment hasn't been shown to work.
WASHINGTON (AP) The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease. Those advocates still face one giant hurdle: FDA regulators say the treatment hasn’t been shown to work. In documents […]
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works journal-news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from journal-news.com Daily Mail and Mail on Sunday newspapers.
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.